Skip to main content

Advertisement

SpringerLink
Log in

Minimising the Side Effects of Cancer Chemotherapy in Senior Patients

  • Review Article
  • Adverse Effects
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Over 50% of cancer deaths occur in persons aged over 65 years, but because of presumed increased toxicity of chemotherapeutic agents in the elderly, they are frequently treated with reduced doses. However, a review of the literature suggests that chronological age alone does not account for increased toxicity in the elderly. If changes in physiological function, the presence of other illness, and the use of concomitant drugs are taken into consideration, chemotherapy can be used safely and effectively in the elderly. However, this knowledge must be used with the understanding that while response rates are not lower in the elderly, the cancers most commonly encountered are notoriously unresponsive to chemotherapy.

Thus, a strategy to use chemotherapy safely and effectively in the elderly involves careful selection of those cancers to be treated, full assessment of the patient’s physiological functions, and a knowledge of the adverse effects of the individual agents used. Finally, the use of a limited treatment plan and an understanding of the principles of symptom relief can help optimise treatment throughout the course of the cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Armitage JO, Potter J. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: increased complications with advancing age. Journal of the American Geriatrics Society 32: 269–273, 1984

    PubMed  CAS  Google Scholar 

  • Balducci L, Parker M, Sexton W, Tantranont P. Pharmacology of antineoplastic agents in the elderly patient. Seminars in Oncology 16: 76–84, 1989

    PubMed  CAS  Google Scholar 

  • Balducci L, Phillips DM, Wallace C, Hardy C. Cancer chemotherapy in the elderly. American Family Physician 35: 133–143, 1987

    PubMed  CAS  Google Scholar 

  • Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly: the experience of the Eastern Cooperative Oncology Group. Cancer 52: 1986–1992, 1983

    Article  PubMed  CAS  Google Scholar 

  • Begg CB, Cohen JL, Ellerton J. Are the elderly predisposed to toxicity from cancer chemotherapy? Cancer Clinical Trials 3: 369–374, 1980

    PubMed  CAS  Google Scholar 

  • Besdine RW. Clinical evaluation of the elderly patient. In Hazzard WR et al. (Eds) Principles of geriatric medicine and gerontology, 2nd ed., pp. 175–183, McGraw-Hill, New York, 1990

    Google Scholar 

  • Bloomfield CD, Theologides A. Acute granulocytic leukemia in elderly patients. Journal of the American Medical Association 226: 1190–1193, 1973

    Article  PubMed  CAS  Google Scholar 

  • Bonadonna G, Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. New England Journal of Medicine 304: 10–15, 1981

    Article  PubMed  CAS  Google Scholar 

  • Boring CC, Squires TS, Tong T. Cancer statistics, 1991. CA-A Cancer Journal for Clinicians 41: 19–51, 1991

    Article  PubMed  CAS  Google Scholar 

  • Brody H. Stories of sickness, Yale University Press, New Haven, 1987

    Google Scholar 

  • Clamon GH, Audeh MW, Pinnick S. Small cell lung carcinoma in the elderly. Journal of the American Geriatrics Society 30: 299–302, 1982

    PubMed  CAS  Google Scholar 

  • Cohen HJ, Silberman HR, Forman W, Bartolucci A, Liu C. Effects of age on responses to treatment and survival of patients with multiple myeloma. Journal of the American Geriatrics Society 31: 272–277, 1983

    PubMed  CAS  Google Scholar 

  • Coltman Jr CA. Chemotherapy of advanced Hodgkin’s disease. Seminars in Oncology 7: 155–173, 1980

    PubMed  Google Scholar 

  • Estey EH, Deating MJ, McCredie KB. Causes of initial remission induction failure in acute myelogenous leukemia. Blood 60: 309–315, 1982

    PubMed  CAS  Google Scholar 

  • Fentiman JS, Tirelli U, Monfardini S, Schneider M, Festen J, et al. Cancer in the elderly: why so badly treated? Lancet 335: 1020–1022, 1990

    Article  PubMed  CAS  Google Scholar 

  • Foon KA, Zighelboim J, Yale C, Gale RP. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia. Blood 58: 467–470, 1981

    PubMed  CAS  Google Scholar 

  • Ganz PA, Coscarelli-Schag C, Heinrich RL. The psychosocial impact of cancer on the elderly: a comparison with younger patients. Journal of the American Geriatrics Society 33: 429–435, 1985

    PubMed  CAS  Google Scholar 

  • Ginsberg SJ, Comis RL. The pulmonary toxicity of antineoplastic agents. Seminars in Oncology 9: 34–51, 1982

    PubMed  CAS  Google Scholar 

  • Glucksgerg H, Cheever MA, Farewell VT. High dose combination chemotherapy for acute nonlymphoblastic leukemia in adults. Cancer 48: 1073–1081, 1981

    Article  Google Scholar 

  • Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. Journal of the American Medical Association 257: 2766–2700, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hoagland HC. Hematologic complications of cancer chemotherpay. Seminars in Oncology 9: 95–102, 1982

    PubMed  CAS  Google Scholar 

  • Hutchins LF, Lipschitz DA. Cancer, clinical pharmacology, and aging. Clinics in Geriatric Medicine 3: 483–504, 1987

    PubMed  CAS  Google Scholar 

  • Kane RL, Ouslander JG, Abrass IB. Changes associated with “normal” aging. In Kane RL et al. (Eds) Essentials of clinical geriatrics, 2nd ed., pp. 4–8, McGraw-Hill, New York, 1989

    Google Scholar 

  • Kaplan RS, Wiernik PH. Neurotoxicity of antineoplastic drugs. Seminars in Oncology 9: 103–130, 1982

    PubMed  CAS  Google Scholar 

  • Kinzel T. Relief of emotional symptoms in elderly patients with terminal cancer. Geriatrics 43: 61–68, 1988a

    PubMed  CAS  Google Scholar 

  • Kinzel T. Symptom control in geriatric patients with terminal cancer: pain, nausea, and vomiting. Geriatrics 43: 83–89, 1988b

    PubMed  CAS  Google Scholar 

  • Lipschitz DA, Udupa KB, Thompson CO. Effect of age on hematopoiesis in man. Blood 63: 502–509, 1984

    PubMed  CAS  Google Scholar 

  • Mitchell EP, Schein PS. Gastrointestinal toxicity of chemotherapeutic agents. Seminars in Oncology 9: 52–64, 1982

    PubMed  CAS  Google Scholar 

  • Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS. Relationship between age at diagnosis and treatments received by cancer patients. Journal of the American Geriatrics Society 33: 585–589, 1985

    PubMed  CAS  Google Scholar 

  • Neilan BA. Management of cancer in the elderly: implications of the aging process. Postgraduate Medicine 77: 143–149, 1985

    PubMed  CAS  Google Scholar 

  • Nerenz DR, Love RR, Leventhal H, Easterling DV. Psychosocial consequences of cancer chemotherapy for elderly patients. Health Services Research 20: 961–976, 1986

    PubMed  CAS  Google Scholar 

  • Pearlman RA. Ethical issues in geriatric care. In Hazzard WR et al. (Eds) Principles of geriatric medicine and gerontology, 2nd ed., pp. 367–382, McGraw-Hill, New York, 1990

    Google Scholar 

  • Perry MC. Hepatotoxicity of chemotherapeutic agents. Seminars in Oncology 9: 65–74, 1982

    PubMed  CAS  Google Scholar 

  • Samet J, Hunt WC, Key C, Humble CG, Goodwin JS. Choice of cancer therapy varies with age of patient. Journal of the American Medical Association 255: 3385–3390, 1986

    Article  PubMed  CAS  Google Scholar 

  • Saunders CM. The philosophy of terminal care. In Saunders CM (Ed.) The management of terminal disease, pp. 103–202, Edward Arnold, London, 1978

    Google Scholar 

  • Schilsky RL. Renal and metabolic toxicities of cancer chemotherapy. Seminars in Oncology 9: 75–83, 1982

    PubMed  CAS  Google Scholar 

  • Scordamaglia A, Ciprandi G, Indiveri F, Caronica GW. The effect of aging on host defences: implications for therapy. Drugs & Aging 1: 303–316, 1991

    Article  CAS  Google Scholar 

  • Tirelli U, Aapro M, Obrist R, Festen J, Scheider M, et al. Cancer treatment and old people. Lancet 338: 114, 1991

    Article  PubMed  CAS  Google Scholar 

  • Von Hoff DD, Rozencweig M, Piccart M. The cardiotoxicity of anticancer agents. Seminars in Oncology 9: 23–33, 1982

    Google Scholar 

  • Walsh SJ, Begg CB, Carbone PP. Cancer chemotherapy in the elderly. Seminars in Oncology 16: 66–75, 1989

    PubMed  CAS  Google Scholar 

  • Wetle T. Age as a risk factor for inadequate treatment. Journal of the American Medical Association 258: 516, 1987

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Human Medicine, Michigan State University, East Lansing, Michigan, USA

    Terry Kinzel

  2. Veterans Affairs Medical Center, Iron Mountain, Michigan, USA

    Terry Kinzel

  3. Copper Country Mental Health Services, Houghton, Michigan, USA

    Terry Kinzel

  4. Medical Oncology, Veterans Affairs Medical Center, Iron Mountain, Michigan, USA

    Virginia Feleppa

Authors
  1. Terry Kinzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virginia Feleppa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kinzel, T., Feleppa, V. Minimising the Side Effects of Cancer Chemotherapy in Senior Patients. Drugs & Aging 2, 137–145 (1992). https://doi.org/10.2165/00002512-199202020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199202020-00007

Keywords

Search

Navigation